Recording: Biomarkers and precision medicine in prostate cancer management
The recording will explore the role of the implementation of biomarkers and precision medicine in the therapeutic algorithm of localised, advanced and metastatic prostate cancer.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
Key opinion leaders will discuss how to apply biomarkers in clinical decision-making, guide treatment intensity, and evaluate the impact of precision strategies on patient outcomes. The recording aims to demonstrate how these tools can help personalise care, reduce overtreatment, and improve survival. The experts will also discuss how to implement novel biomarkers and precision medicine in routine practice.
Speakers:
- Dr. G. Gandaglia (IT)
- Dr. A. Bernard-Tessier (FR)
- Dr. T. Fazekas (HU)
- Dr. D.E. Spratt (US)
This recording is brought to you in collaboration with the EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.